Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PRHSX vs JDOC overlap: 58% of top holdings shared

Bottom line

How much do PRHSX and JDOC overlap?

58% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 49.6% of PRHSX's assets and 52.2% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.

PRHSX holds far more positions (279 vs 61), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PRHSXJDOC
Weight overlap (top 25)58%
Shared holdings13
Weight in shared holdings49.6%52.2%
Total positions27961
Expense ratio0.83%0.65%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings PRHSX and JDOC have in common

Holding% of PRHSX% of JDOCOverlap
Eli Lilly & Co14.28%7.76%7.76%
Johnson & Johnson6.63%4.82%4.82%
Unitedhealth Group Inc5.99%5.85%5.85%
Abbvie Inc5.10%7.85%5.10%
Merck & Co. Inc.4.01%4.82%4.01%
Thermo Fisher Scientific Inc2.52%3.73%2.52%
Bristol-myers Squibb Co2.11%3.57%2.11%
Abbott Laboratories1.89%3.11%1.89%
Intuitive Surgical Inc1.87%1.93%1.87%
Stryker Corp1.78%2.23%1.78%
Danaher Corp1.43%2.16%1.43%
Cardinal Health Inc1.03%1.51%1.03%
Cvs Health Corp0.94%2.83%0.94%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PRHSX

  1. Gilead Sciences Inc — 2.82%
  2. Vertex Pharmaceuticals Inc — 2.28%
  3. Amgen Inc — 1.82%
  4. Elevance Health Inc — 1.53%
  5. Natera Inc — 1.44%
  6. Guardant Health Inc — 1.23%
  7. Royalty Pharma Plc- Cl A — 0.97%
  8. Tenet Healthcare Corp — 0.94%
  9. Kymera Therapeutics Inc — 0.89%
  10. Protagonist Therapeutics Inc — 0.85%
  11. Moderna Therapeutics Inc — 0.83%
  12. Brightspring Health Services — 0.82%

Only in JDOC

  1. AstraZeneca plc — 3.76%
  2. Roche Holding AG — 2.82%
  3. Novo Nordisk A/S — 2.61%
  4. GSK plc — 2.47%
  5. Cencora, Inc. — 2.07%
  6. Argenx SE — 2.06%
  7. Edwards Lifesciences Corp. — 1.73%
  8. IQVIA Holdings, Inc. — 1.71%
  9. Teva Pharmaceutical Industries Ltd. — 1.60%
  10. Regeneron Pharmaceuticals, Inc. — 1.60%
  11. Novartis AG — 1.60%
  12. Biogen, Inc. — 1.56%

Asset mix

Asset typePRHSXJDOC
Stocks96.4%99.2%
Preferred stock3.0%—
Cash & short-term funds0.7%—
Bonds0.2%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryPRHSXJDOC
US92.6%75.2%
GB1.7%6.2%
CH0.5%4.4%
DK0.7%4.0%
JP0.5%2.5%
NL1.0%2.4%
DE—1.9%
IL0.2%1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do PRHSX and JDOC overlap?
About 58% by weight. 13 securities appear in both funds' top 25 holdings; they make up 49.6% of PRHSX's assets and 52.2% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PRHSX and JDOC have in common?
The largest shared holdings are Eli Lilly & Co, Unitedhealth Group Inc, Abbvie Inc, Johnson & Johnson, Merck & Co. Inc..
Should I own both PRHSX and JDOC?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PRHSX or JDOC?
PRHSX is broader, with 279 positions versus 61 for JDOC. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.